InNexus Biotechnology, Inc.

OTCPK:IXSB.F Stock Report

Market Cap: US$154.0

InNexus Biotechnology Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure17.5yrs

Recent management updates

No updates

Recent updates

No updates


CEO

InNexus Biotechnology has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Jur Strobos
Vice President of Clinical & Regulatory Affairs and Member of Scientific Advisory Boardno datano datano data
Daniel Von Hoff
Member of Scientific Advisory Boardno datano datano data
Carlos Arteaga
Member of Scientific Advisory Board17.5yrsno datano data
Ronald Levy
Member of Scientific Advisory Boardno datano datano data
J. Capra
Chairman of Scientific Advisory Board17.6yrsCA$27.60kno data
Maurizio Zanetti
Member of Scientific Advisory Board16.9yrsno datano data
Leroy Chiao
Independent Director17.9yrsCA$64.54kno data
John Minna
Member of Scientific Advisory Boardno datano datano data
Martin Weigert
Member of Scientific Advisory Board17.4yrsno datano data
Ellen Vitetta
Member of Scientific Advisory Boardno datano datano data
Judith James
Member of Scientific Advisory Board16.9yrsno datano data

17.5yrs

Average Tenure

72yo

Average Age

Experienced Board: IXSB.F's board of directors are seasoned and experienced ( 17.5 years average tenure).